News & Perspective

Feb 21, 2019

Feb 21, 2019

Stewardship / Resistance Scan for Feb 21, 2019

XDR gonorrhea clone
New metallo-beta-lactamase
Fast track for pneumonia antibiotic

Aug 09, 2018

Aug 09, 2018

Stewardship / Resistance Scan for Aug 09, 2018

Antibiotic resistance in Australia
New antibiotic for pneumonia, skin infections
Ventilator-associated pneumonia risk factors
Autism and early antibiotic exposure

Oct 17, 2017

Oct 17, 2017

News Scan for Oct 17, 2017

Southern Hemisphere flu decline
Influenza in VA hospitals
H5N6 avian flu in China
H5N8 in South Africa
Hospital-acquired pneumonia

Feb 23, 2011

Feb 23, 2011

CDC explores pneumococcal vaccine link to kids' febrile seizures

(CIDRAP News) – In their ongoing investigation of febrile seizures in young children who were vaccinated against flu this season, experts from the US Centers for Disease Control and Prevention (CDC) said today that they have detected a small excess risk of the condition in those who received the vaccine alongside the new pneumococcal conjugate vaccine.

Dec 08, 2009

Dec 08, 2009

Reports probe Tamiflu benefits, call for clinical data transparency

Dec 9, 2009 (CIDRAP News) – In an update of a review on the role of neuraminidase inhibitors in seasonal flu prevention and treatment, the authors reversed a previous conclusion that oseltamivir (Tamiflu) prevents complications like pneumonia in healthy patients because they were unable to reconstruct the data in one of the key studies that found a benefit.

Oct 16, 2009

Oct 16, 2009

WHO underscores H1N1 risk to young and healthy

(CIDRAP News) – The susceptibility of some young, healthy people to severe illness with pandemic H1N1 influenza marks a striking difference from the pattern of disease seen in seasonal flu epidemics, the World Health Organization (WHO) said today.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»